Markets:

Overview

News

Currencies

International

Treasuries

Edesa Biotech, Inc. - Common Shares (NQ:EDSA)

4.000 +0.140 (+3.63%)

Delayed Quote Updated: 11:27 AM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edesa Biotech, Inc. - Common Shares

< Previous 1 2 3 4 5 6 Next >

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

October 13, 2023

Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance...

Via Benzinga

Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors ↗

January 17, 2023

Via Benzinga

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

October 13, 2023

Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.

Via Benzinga

Why Is Infectious Disease Player Edesa Biotech Stock Soaring Today? ↗

October 12, 2023

Edesa Biotech Inc (NASDAQ: EDSA) has secured a commitment of up to C$23 million from the Government of Canada for a pivotal Phase 3 clinical study of the company's first-in-class therapeutic...

Via Benzinga

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

October 12, 2023

Via ACCESSWIRE

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

October 12, 2023

Via ACCESSWIRE

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 12, 2023

Gainers

Via Benzinga

Edesa Biotech Announces One-for-Seven Reverse Share Split

October 10, 2023

Via ACCESSWIRE

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

September 28, 2023

Via ACCESSWIRE

Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 28, 2023

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...

Via Benzinga

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

August 09, 2023

Via ACCESSWIRE

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

July 26, 2023

Via ACCESSWIRE

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 17, 2023

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

Via InvestorPlace

Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studies ↗

June 28, 2023

Edesa Biotech Inc (NASDAQ: EDSA) released findings from an in vitro study involving its monoclonal antibody candidate, paridiprubart.

Via Benzinga

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

June 28, 2023

Via ACCESSWIRE

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

June 27, 2023

Via ACCESSWIRE

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

May 11, 2023

Via ACCESSWIRE

Edesa Biotech to Participate in Swiss Biotech Day

April 20, 2023

Via ACCESSWIRE

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

April 04, 2023

Via ACCESSWIRE

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

March 23, 2023

Via ACCESSWIRE

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

March 16, 2023

Via ACCESSWIRE

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

March 15, 2023

Via ACCESSWIRE

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

February 10, 2023

Via ACCESSWIRE

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

February 01, 2023

Via ACCESSWIRE

Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket ↗

January 18, 2023

Gainers Siyata Mobile Inc. (NASDAQ: SYTA) rose 41.5% to $0.3255 in pre-market trading after gaining 8% on Tuesday.

Via Benzinga

Nasdaq Edges Higher; Neovasc Shares Jump ↗

January 17, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.

Via Benzinga

Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 17, 2023

Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...

Via Benzinga

Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views ↗

January 17, 2023

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.

Via Benzinga

Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations ↗

January 17, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Tuesday.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.